WithdrawnNCT04311294
Development of a Selective ALDH2 Inhibitor to Treat AUD
Medication studyAges 21+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 21 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: April 2020
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT04311294
- Official title
Show the full official title
Development of a Selective ALDH2 Inhibitor for the Treatment of Alcohol Use Disorder
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Does this study involve medication?
Yes. The study involves medication, including ANS-6637 Low Dose, ANS-6637 High Dose and Matched Placebo.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
